FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZIRESOVIR
异名/同义词4-(4-(((3-AMINOOXETAN-3-YL)METHYL)AMINO)-6-METHYLQUINAZOLIN-2-YL)-2,3,4,5-TETRAHYDRO-1H-1.LAMBDA.6,4-BENZOTHIAZEPINE-1,1-DIONE
4-QUINAZOLINAMINE, N-((3-AMINO-3-OXETANYL)METHYL)-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-
AK0529
AK-0529
N-((3-AMINO-3-OXETANYL)METHYL)-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE
N-((3-AMINOOXETAN-3-YL)METHYL)-2-(1,1-DIOXIDO-2,3-DIHYDRO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYLQUINAZOLIN-4-AMINE
RO-0529
ZIRESOVIR
ZIRESOVIR [INN]
ZIRESOVIR [WHO-DD]
CAS登记号1422500-60-4
物质唯一标识(Unique Ingredient Identifier)XCF42D7AG4
分子式C22H25N5O3S
国际化合物标识(International Chemical Identifier,InChI)GAAICKUTDBZCMT-UHFFFAOYSA-N
SMILESN(CC1(N)COC1)c2c3c(nc(n2)N4Cc5c(S(CC4)(=O)=O)cccc5)ccc(c3)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System